Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1144352 | 1.00 | ALOX15 (0.52) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| Sulfuric Acid SCHEMBL27868432 | 0.91 | ALOX15 (0.44) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL8616862 | 0.85 | ALOX15 (0.52) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL5611950 | 0.84 | ALDH1A1 (0.58) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL5611940 | 0.84 | ALDH1A1 (0.58) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL11141816 | 0.84 | ALDH1A1 (0.58) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL11453082 | 0.83 | ALOX15 (0.50) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL11453081 | 0.83 | ALOX15 (0.50) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL22680428 | 0.82 | ALOX15 (0.44) | ALOX15ALDH1A1LMNAHSD17B10GLO1 | |
| SCHEMBL3360898 | 0.81 | TSHR (0.39) | ALOX15ALDH1A1LMNAHSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0326389-B1 | Process for preparing 4-hydroxypyrimidine | UBE INDUSTRIES (JP) | 1996-09-11 | — | — | EP | claimed |
| EP-0226558-B1 | Chemical intermediates and methods for their preparation | HAESSLE AB (SE) | 1994-04-06 | — | — | EP | claimed |
| US-4935516-A | Process for preparing 4-hydroxypyrimidine | UBE INDUSTRIES, LTD. (JP) | 1990-06-19 | — | — | US | claimed |
| EP-0326389-A2 | Process for preparing 4-hydroxypyrimidine | UBE INDUSTRIES, LTD. (JP) | 1989-08-02 | — | — | EP | claimed |
| EP-0226558-A2 | Chemical intermediates and methods for their preparation | Aktiebolaget Hässle (SE) | 1987-06-24 | — | — | EP | claimed |
| EP-4617260-A1 | PRODUCTION METHOD FOR 1-ALKYL-5-HYDROXYPYRAZOLE | Mitsubishi Gas Chemical Next Company, Inc. (JP) | 2025-09-17 | — | — | EP | disclosed |
| CN-119798144-A | Preparation method of 2-methylpyridine derivative | 湖南大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119529166-A | Polymer dispersant containing sulfonic group, color paste and application thereof | 北京云基科技股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024100791-A1 | PRODUCTION METHOD FOR 1-ALKYL-5-HYDROXYPYRAZOLE | 株式会社日本ファインケム | 2024-05-16 | — | — | WO | disclosed |
| EP-4008715-B1 | HALOGEN SUBSTITUTED COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KEYLAB JIANGSU TECH CO LTD (CN) | 2024-03-06 | — | — | EP | disclosed |
| US-20230345941-A1 | HERBICIDAL PHENYLETHERS | BASF SE (DE) | 2023-11-02 | — | — | US | disclosed |
| US-11472775-B2 | Halogen-substituted compound, preparation method therefor, and use thereof | SUQIAN KEYLAB BIOCHEMICAL CO., LTD. (CN) | 2022-10-18 | — | — | US | disclosed |
| WO-1990006918-A1 | A PROCESS FOR THE PREPARATION OF 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES | CHEMINOVA AGRO A/S (DK) | 1990-06-28 | — | — | WO | disclosed |
| US-4935516-A | Process for preparing 4-hydroxypyrimidine | UBE INDUSTRIES, LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| CN-1042705-A | 3,5-dimethyl-4-methoxypyridine derivatization method and be used for the novel intermediate product of this method for making | CL PHARMA (AT) | 1990-06-06 | — | — | CN | disclosed |
| EP-0326389-A2 | Process for preparing 4-hydroxypyrimidine | UBE INDUSTRIES, LTD. (JP) | 1989-08-02 | — | — | EP | disclosed |
| US-4760163-A | 3-(5-carboxy-4-substituted-phenyl)-(thio)uracil-esters and salts | HOFFMANN-LAROCHE INC. (US) | 1988-07-26 | — | — | US | disclosed |
| US-4746352-A | HERBICIDES | HOFFMANN-LA ROCHE INC. (US) | 1988-05-24 | — | — | US | disclosed |
| CN-86101792-A | The preparation method of heterogeneous ring compound | — | 1986-11-12 | — | — | CN | disclosed |
| US-4358606-A | Esters of phenalkyloxycarbonylamino acids | ZOECON CORPORATION (US) | 1982-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11472775-B2 | Halogen-substituted compound, preparation method therefor, and use thereof | CYP4F11, FAR1, CYP4F8 | ALOX15 705/4885ALDH1A1 93/4885LMNA 4269/4885 |
| US-20230345941-A1 | HERBICIDAL PHENYLETHERS | DDT, HPD, GSTM2 | ALOX15 2239/4885ALDH1A1 35/4885LMNA 3721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.